Topiramate Capsule
Product Images NDC 72888-229

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72888-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Topiramate Cap 15mg 120s Bottle Label)

Image Description (Topiramate Cap 15mg 120s Bottle Label)
Topiramate Capsules, USP 15 mg oral capsules packaging label displaying the product name and strength prominently. The label shows 120 capsules per container, distributed by Advagen Pharma Ltd., and manufactured by Rubicon Research Pvt. Ltd. It includes storage instructions, caution to keep out of reach of children, and a pharmacist advisory to dispense the Medication Guide.*
FDA Label Image

Image Description (Topiramate Cap 15mg 240s Bottle Label)

Image Description (Topiramate Cap 15mg 240s Bottle Label)
Label for Topiramate Capsules, USP 15 mg oral capsules, containing 240 capsules. Distributed by Advagen Pharma Ltd., East Windsor, NJ, USA, and manufactured by Rubicon Research Pvt. Ltd., India. The label includes storage instructions, medication guide information, and a barcode with NDC 72888-228-67.*
FDA Label Image

Image Description (Topiramate Cap 15mg 30s Bottle Label)

Image Description (Topiramate Cap 15mg 30s Bottle Label)
Topiramate 15 mg capsules label showing dosage strength and oral capsule form. The label includes instructions for storage, medication guide availability, and dispensing guidance. It is distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Pvt. Ltd. The package contains 30 capsules with NDC 72888-228-30.*
FDA Label Image

Image Description (Topiramate Cap 15mg 500s Bottle Label)

Image Description (Topiramate Cap 15mg 500s Bottle Label)
Topiramate Capsules, USP 15 mg oral capsules label showing a package of 500 capsules. Distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Pvt. Ltd., the label includes storage instructions, barcode, and a note for pharmacists to dispense the Medication Guide. The label features the NDC 72888-228-05 and highlights the 15 mg strength in a pink box.*
FDA Label Image

Image Description (Topiramate Cap 15mg 60s Bottle Label)

Image Description (Topiramate Cap 15mg 60s Bottle Label)
Topiramate Capsules, USP 15 mg oral capsules packaging label from Advagen Pharma Ltd. The label states each capsule contains 15 mg of Topiramate and the package contains 60 capsules. Storage instructions specify 20° to 25°C with excursions allowed between 15° to 30°C. Distributed by Advagen Pharma Ltd., manufactured by Rubicon Research Pvt. Ltd., India. Includes a barcode and a note to dispense a medication guide to patients.*
FDA Label Image

Image Description (Topiramate Cap 25mg 120s Bottle Label)

Image Description (Topiramate Cap 25mg 120s Bottle Label)
Topiramate Capsules USP 25 mg oral capsules label by Advagen Pharma Ltd. The label indicates the product contains 120 capsules per container, includes storage instructions to keep at 20° to 25°C, and directs pharmacists to dispense the medication guide with the product. Manufactured by Rubicon Research Pvt. Ltd., India, with distributor information for Advagen Pharma in New Jersey, USA. The label includes barcode and medication guide web link details.*
FDA Label Image

Image Description (Topiramate Cap 25mg 240s Bottle Label)

Image Description (Topiramate Cap 25mg 240s Bottle Label)
Label for Topiramate Capsules USP 25 mg in a 240-capsule package. The label includes the NDC 72888-229-67 and states the product is distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Pvt. Ltd. Storage instructions, dosage guidance referral, and a medication guide URL are provided. The label features the Advagen logo.*
FDA Label Image

Image Description (Topiramate Cap 25mg 30s Bottle Label)

Image Description (Topiramate Cap 25mg 30s Bottle Label)
Label from Topiramate Capsules, USP 25 mg, oral capsules, from Advagen Pharma Ltd. The label includes dosage strength, pharmacist dispensing instructions, storage conditions, bar code, distributor and manufacturer information, and a website for the medication guide and package insert. The package contains 30 capsules.*
FDA Label Image

Image Description (Topiramate Cap 25mg 500s Bottle Label)

Image Description (Topiramate Cap 25mg 500s Bottle Label)
Label for Topiramate Capsules, USP 25 mg, a human prescription oral capsule product. The label states distribution by Advagen Pharma Ltd., East Windsor, NJ, and manufacturing by Rubicon Research Pvt. Ltd., India. The package size is 500 capsules. Storage instructions and a medication guide website are included.*
FDA Label Image

Image Description (Topiramate Cap 25mg 60s Bottle Label)

Image Description (Topiramate Cap 25mg 60s Bottle Label)
Label for Topiramate Capsules, USP 25 mg, oral capsules, supplied in a package of 60 capsules. Distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Pvt. Ltd. The label includes storage instructions, pharmacist dispensing guidance, and mentions this is a prescription-only drug.*
FDA Label Image

Image Description (Topiramate Cap 50mg 120s Bottle Label)

Image Description (Topiramate Cap 50mg 120s Bottle Label)
Label for Topiramate Capsules, USP 50 mg, oral dosage form in a package of 120 capsules. The label shows the product strength as 50 mg, includes storage instructions, distributor Advagen Pharma Ltd, and manufacturer Rubicon Research Pvt. Ltd. The label also mentions a medication guide link and the product is Rx only.*
FDA Label Image

Image Description (Topiramate Cap 50mg 240s Bottle Label)

Image Description (Topiramate Cap 50mg 240s Bottle Label)
Topiramate Capsules USP 50 mg capsule label by Advagen Pharma Ltd. The label states storage instructions, packaging of 240 capsules, and includes distributor and manufacturer information. It features a barcode, NDC 72888-230-67, and a pharmacist instruction to dispense the Medication Guide with each patient.*
FDA Label Image

Image Description (Topiramate Cap 50mg 30s Bottle Label)

Image Description (Topiramate Cap 50mg 30s Bottle Label)
Topiramate Capsules USP 50 mg label showing a 30-capsule count container. Distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. Instructions include storage at 20° to 25°C with excusions permitted to 15° to 30°C, keep out of reach of children, and pharmacist dispensing note to provide medication guide to patients. Barcode and revision date 09/24 are also visible.*
FDA Label Image

Image Description (Topiramate Cap 50mg 500s Bottle Label)

Image Description (Topiramate Cap 50mg 500s Bottle Label)
Topiramate Capsules, USP 50 mg oral capsules label showing the NDC 72888-230-05. The label indicates the product is distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Pvt. Ltd. The package contains 500 capsules. Storage directions and a medication guide URL are also present on the label.*
FDA Label Image

Image Description (Topiramate Cap 50mg 60s Bottle Label)

Image Description (Topiramate Cap 50mg 60s Bottle Label)
Topiramate Capsules, USP 50 mg oral capsules label showing the product name, strength, and dosage form. The label indicates a package size of 60 capsules and lists Advagen Pharma Ltd. as the distributor and Rubicon Research Pvt. Ltd. as the manufacturer. Storage and handling instructions are provided alongside a medication guide URL.*
FDA Label Image

Image Description (Topiramate Cap Graph 1)

Image Description (Topiramate Cap Graph 1)
A line graph showing cumulative rates for time to first seizure over a period of 500 days comparing Topiramate 50 mg/day and 400 mg/day dosing groups with sample sizes of 234 and 236 respectively. The graph includes a p-value of 0.0002 indicating statistical analysis of the data.*
FDA Label Image

Image Description (Topiramate Cap Graph 2)

Image Description (Topiramate Cap Graph 2)
A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate with different doses of Topiramate (50 mg/day, 100 mg/day, 200 mg/day) compared to placebo. Data is presented for two studies (Study 11 and Study 12), with error bars indicating standard error. Statistical significance is noted at p < 0.010 and p < 0.001 levels.*
FDA Label Image

Image Description (Topiramate Cap Structure)

Image Description (Topiramate Cap Structure)
Chemical structure diagram of Topiramate, displaying its molecular framework including rings, oxygen, sulfur, and amine groups. The diagram highlights Topiramate's distinctive arrangement of atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.